Clinical Trials Directory

Trials / Sponsors / Genaera Corporation

Genaera Corporation

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedAn Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers
Diabetes Mellitus, Obesity
Phase 12008-11-01
CompletedA Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers
Diabetes Mellitus, Obesity
Phase 12008-01-01
CompletedA Tolerance and Pharmacokinetic Study of Trodusquemine in Healthy Volunteers
Obesity
Phase 12007-05-01
TerminatedA Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
Macular Degeneration
Phase 22006-05-01
TerminatedA Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Dege
"Wet" Age-Related Macular Degeneration
Phase 32005-06-01
TerminatedMSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Dege
Macular Degeneration
Phase 22004-10-01
TerminatedA Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration
Macular Degeneration
Phase 22004-08-01